LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

LLY

1,005.35

-1.92%↓

JNJ

246.09

-0.44%↓

ABBV

233.53

+0.32%↑

NVS

163.18

-2.06%↓

MRK

120.37

-0.97%↓

Search

Vivani Medical

Open

1.18 -3.28

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.1400000000000001

Max

1.24

Belangrijke statistieken

By Trading Economics

Werknemers

37

Dividenden

By Dow Jones

Volgende Winsten

30 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-19M

86M

Vorige openingsprijs

4.46

Vorige sluitingsprijs

1.18

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 mrt 2026, 23:41 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2 mrt 2026, 23:37 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2 mrt 2026, 23:26 UTC

Belangrijke Nieuwsgebeurtenissen

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2 mrt 2026, 22:41 UTC

Marktinformatie

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2 mrt 2026, 22:32 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 22:32 UTC

Marktinformatie

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2 mrt 2026, 22:21 UTC

Marktinformatie

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2 mrt 2026, 22:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

2 mrt 2026, 22:11 UTC

Marktinformatie

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2 mrt 2026, 22:10 UTC

Acquisities, Fusies, Overnames

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2 mrt 2026, 22:06 UTC

Marktinformatie

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2 mrt 2026, 22:00 UTC

Marktinformatie
Winsten

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 22:00 UTC

Marktinformatie
Winsten

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

2 mrt 2026, 21:35 UTC

Acquisities, Fusies, Overnames

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2 mrt 2026, 21:34 UTC

Acquisities, Fusies, Overnames

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2 mrt 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mrt 2026, 21:17 UTC

Belangrijke Nieuwsgebeurtenissen

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2 mrt 2026, 20:44 UTC

Winsten

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mrt 2026, 20:43 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Treasury Yields Rise, Dollar Strengthens After Attack on Iran -- Market Talk

2 mrt 2026, 20:28 UTC

Winsten

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2 mrt 2026, 20:25 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2 mrt 2026, 20:24 UTC

Winsten

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mrt 2026, 20:14 UTC

Acquisities, Fusies, Overnames

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mrt 2026, 20:12 UTC

Belangrijke Nieuwsgebeurtenissen

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2 mrt 2026, 20:08 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 20:08 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2 mrt 2026, 20:05 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financieel

$

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
help-icon Live chat